Vanderbilt University Medical Center: Rheumatoid Arthritis Patients on Medicare Seeing Increased Out-of-Pocket Costs for Specialty Medications
May 08, 2020
May 08, 2020
NASHVILLE, Tennessee, May 8 -- Vanderbilt University Medical Center issued the following news:
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Led by Vanderbilt University School of Medicine student Alex . . .
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Led by Vanderbilt University School of Medicine student Alex . . .